# Isracann Biosciences Inc. (ISCNF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ISCNF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2022 | $ 0 | $ -3.93M | $ -965.9K | $ 0 | $ 128.2K |
| 2021 | $ 0 | $ -27.67M | $ -3.71M | $ 0 | $ 2.64M |
| 2020 | $ 0 | $ -26.70M | $ -8.08M | $ 0 | $ 24.45M |
| 2019 | $ 250.8K | $ -5.92M | $ -6.32M | $ 410.3K | $ 51.22M |
| 2018 | $ 2.52M | $ -17.65M | $ -10.04M | $ 0 | $ 6.13M |
| 2017 | $ 449.9K | $ -2.83M | $ -4.40M | $ 40.0K | $ 5.53M |
| 2016 | $ 342.9K | $ -777.1K | $ -559.7K | $ 1.02M | $ 235.2K |
| 2015 | $ 139.0K | $ -573.8K | $ -377.1K | $ 0 | $ 943.7K |
| 2014 | $ 0 | $ -598.9K | $ -830.0K | $ 0 | $ 1.18M |
| 2013 | $ 0 | $ -114.0K | $ -100.0K | $ 0 | $ 195.3K |
| 2012 | $ 0 | $ -131.0K | $ -134.6K | $ 0 | $ 280.5K |
| 2011 | $ 0 | $ -83.2K | $ -76.5K | $ 0 | $ 343.4K |
| 2010 | $ 0 | $ -137.2K | $ -159.1K | $ 0 | $ 429.1K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 30.54 |
| Current Ratio | 0.30 |

## Other views

- [Metrics](https://sponda.capital/en/ISCNF.md)
- [Charts](https://sponda.capital/en/ISCNF/charts.md)
- [Compare](https://sponda.capital/en/ISCNF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.